Katherine J. Bangen

Katherine J. Bangen

Auto-generated profile, based on publicly available information

Katherine J. Bangen

University of California, San Diego, La Jolla, CA, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in The American Journal of Geriatric Psychiatry
Verified
Journal Article
Closed access
KBKatherine J. Bangen
Katherine J. Bangen
TMThomas W. Meeks
Thomas W. Meeks
DJDilip V. Jeste
Dilip V. Jeste

10 September 2018 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
KBKatherine J. Bangen
Katherine J. Bangen
MWMadeleine L. Werhane
Madeleine L. Werhane
AWAlexandra J. Weigand
Alexandra J. Weigand
EEEmily C. Edmonds
Emily C. Edmonds
LDLisa Delano-Wood
Lisa Delano-Wood
MBMark W. Bondi
Mark W. Bondi
Type 2 diabetes mellitus (T2DM) increases risk for dementia, including Alzheimer’s disease (AD). Many previous studies of brain changes underlying cognitive impairment in T2DM have applied conventional structural magnetic resonance imaging (MRI) to detect macrostructural changes associated with cerebrovascular disease such as white matter hyperintensities or infarcts. However, such pathology likely reflects end-stage manifestations of chronic decrements in cerebral blood flow (CBF). MRI techniques that measure CBF may (1) elucidate mechanisms that precede irreversible parenchymal damage and (2) serve as a marker of risk for cognitive decline. CBF measured with arterial spin labeling (ASL) MRI may be a useful marker of perfusion deficits in T2DM and related conditions. We examined associations among T2DM, CBF, and cognition in a sample of 49 well-characterized nondemented older adults. Along with a standard T1-weighted scan, a pseudocontinuous ASL sequence optimized for older adults (by increasing post-labeling delays to allow more time for the blood to reach brain tissue) was obtained on a 3T GE scanner to measure regional CBF in FreeSurfer derived regions of interest. Participants also completed a neuropsychological assessment. Results showed no significant differences between individuals with and without T2DM in terms of cortical thickness or regional brain volume. However, adjusting for age, sex, comorbid vascular risk factors, and reference CBF (postcentral gyrus) older adults with T2DM demonstrated reduced CBF in the hippocampus, and inferior temporal, inferior parietal, and frontal cortices. Lower CBF was associated with poorer memory and executive function/processing speed. When adjusting for diabetes, the significant associations between lower regional CBF and poorer executive function/processing speed remained. Results demonstrate that CBF is reduced in older adults with T2DM, and suggest that CBF alterations likely precede volumetric changes. Notably, relative to nondiabetic control participants, those with T2DM showed lower CBF in predilection sites for AD pathology (medial temporal lobe and inferior parietal regions). Findings augment recent research suggesting that perfusion deficits may underlie cognitive decrements frequently observed among older adults with T2DM. Results also suggest that CBF measured with ASL MRI may reflect an early and important marker of risk of cognitive impairment in T2DM and related conditions.

1 November 2013 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
KBKatherine J. Bangen
Katherine J. Bangen
ABAlexa Beiser
Alexa Beiser
LDLisa Delano-Wood
Lisa Delano-Wood
DNDaniel A. Nation
Daniel A. Nation
MLMelissa Lamar
Melissa Lamar
RARhoda Au
Rhoda Au

1 January 2018 in Alzheimer Disease & Associated Disorders
Verified
Journal Article
Open access
KBKatherine J. Bangen
Katherine J. Bangen
SPSarah R. Preis
Sarah R. Preis
LDLisa Delano-Wood
Lisa Delano-Wood
PWPhilip A. Wolf
Philip A. Wolf
DLDavid J. Libon
David J. Libon
ABAdam M. Brickman
Adam M. Brickman
Introduction: We examined associations between magnetic resonance imaging (MRI) markers of cerebrovascular disease and neurodegeneration with mild cognitive impairment (MCI) diagnosis at baseline and conversion from normal cognition to MCI at follow-up.Methods: Framingham Offspring participants underwent brain MRI and neuropsychological assessment at baseline (n=1049) and follow-up (n=561). Participants were classified at baseline and at follow-up as cognitively normal or MCI using sensitive neuropsychological criteria. White matter hyperintensity (WMH) volume, covert brain infarcts, hippocampal volume, and total cerebral brain volume were quantified.Results: Baseline measures of WMH and hippocampal volume were associated with MCI status cross-sectionally and also with conversion from normal cognition to MCI at 6.5-year follow-up. Annualized change rates in total cerebral brain volume and hippocampal volume were associated with conversion from normal cognition to MCI to follow-up.Discussion: Baseline WMH and hippocampal volume are markers that are both associated with conversion from normal cognition to MCI, highlighting the role of both vascular lesions and neurodegeneration in MCI.

8 June 2017 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
KBKatherine J. Bangen
Katherine J. Bangen
ACAlexandra L. Clark
Alexandra L. Clark
EEEmily C. Edmonds
Emily C. Edmonds
NENicole D. Evangelista
Nicole D. Evangelista
MWMadeleine L. Werhane
Madeleine L. Werhane
LDLisa Delano-Wood
Lisa Delano-Wood
Cerebral blood flow (CBF) alterations and amyloid-B (AB) accumulation have been independently linked to cognitive deficits in older adults at risk for dementia. Less is known about how CBF and AB may interact to affect cognition in cognitively normal older adults. Therefore, we examined potential statistical interactions between CBF and AB status in regions typically affected in Alzheimer’s disease (AD) within a sample of older adults from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) study. Sixty-two cognitively normal participants (mean age=72 years) underwent neuroimaging and memory testing. Arterial spin labeling (ASL) magnetic resonance imaging (MRI) was used to quantify CBF and florbetapir PET amyloid imaging was used to measure A deposition. AB status (i.e., positivity versus negativity) was determined based on established cutoffs (Landau et al., 2013). The Rey Auditory Verbal Learning Test (RAVLT) was used to assess memory. Linear regression models adjusted for age, education, and sex, demonstrated significant interactions between CBF and AB status on memory performance. Among AB positive older adults, there were significant negative associations between higher CBF in hippocampus, posterior cingulate, and precuneus and poorer memory performance. In contrast, among AB negative older adults, there were no significant associations between CBF and cognition. Our findings extend previous CBF studies of dementia risk by reporting interactions between AB status and CBF on memory performance in a sample of well-characterized, cognitively normal older adults. Results suggest that differential CBF-cognition associations can be identified in healthy, asymptomatic AB positive older adults relative to AB negative individuals. Associations between higher CBF and poorer memory among AB positive older adults may reflect a cellular and/or vascular compensatory response to pathologic processes whereby higher CBF is needed to maintain normal memory abilities. Findings indicate that CBF and its associations with cognition may have utility as a reliable marker of brain function early in the AD process when interventions are likely to be beneficial.

23 May 2016 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
KBKatherine J. Bangen
Katherine J. Bangen
FIFor The Alzheimer’S Disease Neuroimaging Initiative
For The Alzheimer’S Disease Neuroimaging Initiative
ACAlexandra L. Clark
Alexandra L. Clark
MWMadeline Werhane
Madeline Werhane
EEEmily C. Edmonds
Emily C. Edmonds
LDLisa Delano-Wood
Lisa Delano-Wood
We examined cortical amyloid-β (Aβ) levels and interactions with apolipoprotein (APOE) ɛ 4 genotype status across empirically-derived mild cognitive impairment (MCI) subgroups and cognitively normal older adults. Participants were 583 ADNI participan